About the The Lancet Infectious Diseases format
The Lancet Infectious Diseases is a peer-reviewed journal published by Clinical & Medical Journals, covering Viral Infections and Outbreaks Research, Tuberculosis Research and Epidemiology, Mosquito-borne diseases and control. Over its lifetime it has published 10,851 papers, which have received 653,270 citations.
| Publisher | Clinical & Medical Journals |
|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text
1. Smith A, Jones B, Lee C. A representative article title. The Lancet Infectious Diseases. 2023;12(3):45–58.
Formats any DOI in The Lancet Infectious Diseases style. No sign-up.
|
|---|
| Publishes research in | Viral Infections and Outbreaks Research Tuberculosis Research and Epidemiology Mosquito-borne diseases and control SARS-CoV-2 and COVID-19 Research Pneumonia and Respiratory Infections |
|---|
| ISSN | 1473-3099 |
|---|
| Citation impact (2-yr) | 10.93 |
|---|
| h-index | 372 |
|---|
| i10-index | 4,106 |
|---|
| Article processing charge | $6,300 |
|---|
| Top institutions publishing here | London School of Hygiene & Tropical Medicine |
|---|
| Journal website | www.journals.elsevier.com |
|---|
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
|---|
Papers published in The Lancet Infectious Diseases per year
Citation impact of The Lancet Infectious Diseases by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in The Lancet Infectious Diseases
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong, Hongru Du, Lauren Gardner · 19 Feb 2020
In December, 2019, a local outbreak of pneumonia of initially unknown cause was detected in Wuhan (Hubei, China), and was quickly determined to be caused by a novel coronavirus,1WHOWHO statement regarding cluster of pneumonia cases in Wuhan, China.https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-chinaDate: Jan 9, 2020Date accessed: February 11, 2020Google Scholar namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The…
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · 21 Dec 2017
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · 18 Nov 2015
Antibiotic resistance—the need for global solutions
Ramanan Laxminarayan, Adriano Dusé, Chand Wattal et al. · 16 Nov 2013
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Robert Verity, Lucy Okell, Ilaria Dorigatti et al. · 30 Mar 2020
BACKGROUND: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases. METHODS: We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China…
